Trial Profile
A first in man trial of NX-AS-401
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2018
Price :
$35
*
At a glance
- Drugs NX AS 401 (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions; First in man
- 01 Aug 2018 New trial record